Article
Rethinking Tolerability Measurement in Oncology Trials
Do current PRO measures in oncology trials capture true tolerability? Bill Byrom and John Peipert examine three critical gaps sponsors need to...
Your consultation request
has been received.
Thank you. A member of our team will be in touch within one business day to confirm your consultation and connect you with the appropriate scientific expert for your indication and phase.
In the meantime, you can explore more oncology trial design resources.
Webinar
Measuring Treatment Tolerability in Oncology: Expert Panel Discussion
Learn from oncology development experts about patient-reported outcome strategies for tolerability assessment, regulatory submission enhancement, and...
Article
The Hidden Problem in Early Phase Oncology Trials
Early phase oncology trials can benefit from using PROMs to ensure accurate dosing and improve patient outcomes. Learn more about this approach.